(26 November 2020) – The Commission has adopted a Pharmaceutical Strategy for Europe to “ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry.”
The Strategy will allow Europe to cover its pharmaceutical needs, including in times of crisis, through robust supply chains.
A key component of building a stronger European Health Union, the Strategy will help to establish a future-proof and crisis-resilient EU pharmaceutical system.
The Pharmaceutical Strategy for Europe marks the beginning of a process: its implementation includes an agenda of legislative and non-legislative actions which will be launched over the coming years.